COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 84: Line 84:
'''Endocrinology and COVID-19'''
'''Endocrinology and COVID-19'''
*'''[[User:Tayyaba Ali|Tayyaba Ali, M.D.]]'''
*'''[[User:Tayyaba Ali|Tayyaba Ali, M.D.]]'''
'''Infectious diseases and COVID'''
*Harmeet, MD
*Zaida, MD

Revision as of 18:42, 27 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

  • The name of the leaders are written in bold:

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and COVID-19

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members

Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members

Pediatrics and COVID-19

Pulmonary Disorders and COVID-19 Team Members

Endocrinology and COVID-19

Infectious diseases and COVID

  • Harmeet, MD
  • Zaida, MD